In reply

Prashant Kapoor; Morie A. Gertz; Stephen M. Ansell

In reply

Prashant Kapoor, Morie A. Gertz, Stephen M. Ansell

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	745-746
Number of pages	2
Journal	JAMA Oncology
Volume	4
Issue number	5
State	Published - May 2018

ASJC Scopus subject areas

Oncology
Cancer Research

Cite this

@article{d862c279e9aa4cf0a018a31ae3fe7722,

title = "In reply",

author = "Prashant Kapoor and Gertz, {Morie A.} and Ansell, {Stephen M.}",

note = "Funding Information: Conflict of Interest Disclosures: Dr Kapoor is principal investigator on studies for which Mayo Clinic receives funding from Takeda, Sanofi, and Amgen. Dr Gertz has received research support from Ionis Pharmaceuticals and Prothena, and honoraria from Celgene, Millennium Pharmaceuticals, and Novartis. Dr Ansell reports grants from Takeda, Bristol-Myers Squibb, Affimed, Seattle Genetics, Regeneron, and Trillium. No other disclosures are reported.",

year = "2018",

month = may,

language = "English (US)",

volume = "4",

pages = "745--746",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - In reply

AU - Kapoor, Prashant

AU - Gertz, Morie A.

AU - Ansell, Stephen M.

N1 - Funding Information: Conflict of Interest Disclosures: Dr Kapoor is principal investigator on studies for which Mayo Clinic receives funding from Takeda, Sanofi, and Amgen. Dr Gertz has received research support from Ionis Pharmaceuticals and Prothena, and honoraria from Celgene, Millennium Pharmaceuticals, and Novartis. Dr Ansell reports grants from Takeda, Bristol-Myers Squibb, Affimed, Seattle Genetics, Regeneron, and Trillium. No other disclosures are reported.

PY - 2018/5

Y1 - 2018/5

UR - http://www.scopus.com/inward/record.url?scp=85047499983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047499983&partnerID=8YFLogxK

M3 - Letter

C2 - 29392293

AN - SCOPUS:85047499983

SN - 2374-2437

VL - 4

SP - 745

EP - 746

JO - JAMA Oncology

JF - JAMA Oncology

IS - 5

ER -

In reply

ASJC Scopus subject areas

Other files and links

Cite this